Skip to main content

Advertisement

Table 3 Count of activities mentioned in pharmacovigilance excerpts from Africa, stratified by type (N = 188)

From: Donor support for quality assurance and pharmacovigilance of anti-malarials in malaria-endemic countries

Pharmacovigilance area of interest
Activity type Adverse events Counterfeit drugs Drug quality assurance PV NOS NA Total
 Behaviour change communication   3 (75.0) 1 (25.0)    4 (2.1)
 Improve regulatory system   5 (19.2) 12 (46.2) 9 (34.6)   26 (13.8)
 Improving supply chain    5 (45.4) 6 (54.5)   11 (5.9)
 Laboratory supplies and training   4 (18.2) 17 (77.3) 1 (4.5)   22 (11.7)
 Operations research 2 (100)      2 (1.1)
 Pharmacovigilance NOS 2 (8.7) 5 (21.7) 15 (65.2) 1 (4.3)   23 (12.2)
 Surveillance 2 (9.5) 5 (23.8) 13 (61.9) 1 (4.8)   21 (11.2)
 Training/capacity building    5 (55.6) 4 (44.4)   9 (4.8)
 Surveillance-not funded 1 (100)      1 (0.5)
 Pharmacovigilance NOS-unfunded    6 (100)    6 (3.2)
 Context onlya      35 (100) 35 (18.6)
 Historical activityb   6 (13.3) 26 (57.8) 12 (26.7) 1 (3.8) 45 (23.9)
 Total 7 (3.7) 22 (11.7) 94 (50.0) 35 (18.6) 36 (19.1) 188 (100.0)
  1. aExcerpts that described pharmacovigilance activities occurring within the country but that were not supported or funded by the current or past grants
  2. bExcerpts that described pharmacovigilance activities that were previously funded by the grant making organization but were not being supported in the current grant